ARCHIVES

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

New guidelines for Cancer Center Support Grants will enable centers to apply for salary support for clinical investigators.

October 8, 2004

Scrutiny of caBIG Exposes Conflicts, Bonanza For Contractors

March 18, 2011

AACI Developing Suggestions Or New Cancer Control Grant Guidelines

July 20, 1979

Xeloda As Effective As 5-FU/LV, Five-Year Survival Data Show

September 28, 2007

To Wage New War On Cancer, Advocates Plan A Campaign Inspired By Earth Day

October 31, 1997

NCA Uneasy Over Possible NIH Takeover Of FCRC, But It Won’t Happen

June 13, 1980